Inspirna, Inc.

Inspirna, Inc. is a privately held, clinical-stage biopharmaceutical company focused on developing innovative cancer therapies. They specialize in discovering and developing novel cancer drugs that target key pathways in cancers with high unmet need. Inspirna leverages its proprietary RNA-DRIVEr™ platform, which utilizes microRNA profiling to uncover previously unknown cancer drivers. This platform enables them to identify new targets for their first-in-class small molecules and biologics, aiming to provide more practical and effective treatment options that prolong patient survival without compromising quality of life.

Their pipeline includes several drug candidates in various stages of clinical development. Ompenaclid (RGX-202), their lead drug candidate, targets the CKB/SLC6A8 pathway, which is activated in certain gastrointestinal cancers. Abequolixron (RGX-104) is another clinical-stage candidate, targeting the LXR/APOE pathway to inhibit angiogenesis and enhance the immune response. Inspirna has a distinguished scientific team, a seasoned board of directors, and has secured funding from leading biotechnology investors. Their focus on developing innovative therapies and their robust pipeline positions them as a promising player in the fight against cancer.

Inspirna offers a variety of workplace benefits including paid time off, medical, dental and vision insurance, flexible spending accounts, tuition assistance and commuter benefits. However, the company website doesn't mention any details on job flexibility, such as remote work options or flexible scheduling.

Inspirna, Inc. offers a comprehensive package of employee benefits to attract and retain top talent. These include discretionary bonuses and stock options for strong performance, a 401(k) plan to help employees save for retirement, medical, dental and vision insurance to cover health needs, flexible spending and health savings accounts to manage healthcare expenses, employer-paid short-term and long-term disability insurance, group life insurance, workers' compensation, paid time off, commuter benefits, and tuition assistance for continued learning and development.

Inspirna, Inc. is a privately-held clinical-stage biopharmaceutical company focused on developing first-in-class cancer therapeutics that target previously untreatable common cancers. Their mission is to convert cancer to a manageable, chronic condition by exposing newly discovered drivers of metastasis through their proprietary RNA-DRIVEr™ platform and microRNA mapping, ultimately providing more practical treatment options that prolong survival without decreasing patients’ quality of life.

Inspirna fosters a culture of collaboration, integrity, and innovation, prioritizing a teamwork-oriented approach to develop groundbreaking therapies for cancer patients. The company values diversity and inclusion, believing that a wide range of perspectives leads to impactful work. Inspirna is committed to professional growth and employee well-being, encouraging its team to achieve their best both inside and outside the workplace.

Inspirna values diversity and inclusion in everything they do, seeking to build a team of talented innovators and leaders who represent a variety of backgrounds and perspectives. They are committed to a purposeful and teamwork-oriented culture, believing that diverse perspectives coupled with their drug discovery and development experience will make their work more impactful. Inspirna also prioritizes professional growth and wellness for their employees, wanting them to thrive both inside and outside of the lab and office.